Geniposide improves bleomycin-induced pulmonary fibrosis by inhibiting NLRP3 inflammasome activation and modulating metabolism (vol 104, 105503, 2023)

被引:0
|
作者
Wei, Yi [1 ]
Liu, Chao [2 ,4 ]
Li, Lujia [3 ,5 ]
机构
[1] Shandong Univ Tradit Chinese Med, Dept Tradit Chinese Med, Jinan 250355, Peoples R China
[2] Qingdao Hiser Hosp, Qingdao Tradit Chinese Med Hosp, Dept Med Imaging, Qingdao 266014, Peoples R China
[3] Peoples Liberat Army Navy 971 Hosp, Dept Hlth Care, Qingdao 266071, Peoples R China
[4] Qingdao Hiser Hosp, QingdaoTradit Chinese Med Hosp, Dept Med Imaging, 4th Renmin Rd, Qingdao 266014, Peoples R China
[5] Peoples Liberat Army Navy 971 Hosp, Dept Hlth Care, Shandong Rd, Qingdao 266071, Peoples R China
关键词
D O I
10.1016/j.jff.2023.105910
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Geniposide improves bleomycin-induced pulmonary fibrosis by inhibiting NLRP3 inflammasome activation and modulating metabolism
    Wei, Yi
    Liu, Chao
    Li, Lujia
    JOURNAL OF FUNCTIONAL FOODS, 2023, 104
  • [2] Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis
    Liang, Qing
    Cai, Wuyang
    Zhao, Yaxue
    Xu, Huanbai
    Tang, Huirong
    Chen, Daijie
    Qian, Feng
    Sun, Lei
    PHARMACOLOGICAL RESEARCH, 2020, 158
  • [3] Iguratimod ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the EMT process and NLRP3 inflammasome activation
    Liu, Wenping
    Han, Xiao
    Li, Qing
    Sun, Linqian
    Wang, Jibo
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [4] Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
    Abd-Elmawla, Mai A.
    Ghaiad, Heba R.
    Gad, Enas S.
    Ahmed, Kawkab A.
    Abdelmonem, Maha
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2023, 24 (08): : 723 - 733
  • [5] IGURATIMOD AMELIORATES BLEOMYCIN-INDUCED PULMONARY FIBROSIS VIA INHIBITINGEMT PROCESS AND NLRP3 INFLAMMASOME ACTIVATION
    Liu, W.
    Li, Q.
    Han, X.
    Sun, L.
    Wang, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 462 - 462
  • [6] Exploring the mitigating potential of anthocyanin Malvidin in a mouse model of bleomycin-induced pulmonary fibrosis by inhibiting NLRP3 inflammasome activation and oxidative stress
    Zhou, Dingzi
    Cai, Lin
    Xu, Jie
    Fu, Daigang
    Yan, Ling
    Xie, Linshen
    JOURNAL OF INFLAMMATION-LONDON, 2025, 22 (01):
  • [7] NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis
    Tian, Rui
    Zhu, Yong
    Yao, Jiayi
    Meng, Xiaoxiao
    Wang, Jinfeng
    Xie, Hui
    Wang, Ruilan
    EXPERIMENTAL CELL RESEARCH, 2017, 357 (02) : 328 - 334
  • [8] L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis
    Joshi, Hemant
    Almgren-Bell, Alison
    Anaya, Edgar P.
    Todd, Elizabeth M.
    Van Dyken, Steven J.
    Seth, Anushree
    McIntire, Katherine M.
    Singamaneni, Srikanth
    Sutterwala, Fayyaz
    Morley, Sharon C.
    CELL REPORTS, 2022, 38 (11):
  • [9] NLRP3 Inflammasome Activation Is Involved in Geniposide-Induced Hepatotoxicity
    Liu, Yixuan
    Liu, Baoyue
    Shi, Mingzhu
    Ye, Tianxiang
    Li, Huifang
    MEDIATORS OF INFLAMMATION, 2025, 2025 (01)
  • [10] Bone morphogenetic protein 4 ameliorates bleomycin-induced pulmonary fibrosis in mice by repressing NLRP3 inflammasome activation and epithelial-mesenchymal transition
    Xu, Xin
    Yuan, Liang
    Hu, Xiao
    Li, Jingpei
    Wu, Huihui
    Chen, Fang
    Huang, Fei
    Kong, Weiguo
    Liu, Wei
    Xu, Jingyi
    Zhou, You
    Zou, Yunhan
    Shen, Yi
    Guan, Ruijuan
    He, Jianxing
    Lu, Wenju
    JOURNAL OF THORACIC DISEASE, 2024, 16 (08) : 4875 - 4891